Incidence and mortality estimate of pancreatic diseases hospitalized in the Brazilian Unified Health System
DOI:
https://doi.org/10.47456/rbps.v25isupl_2.40998Keywords:
Pancreatitis, Pancreas, Incidence, Mortality, SUSAbstract
Introduction: Acute pancreatitis, chronic pancreatitis and pancreatic cancer are the most common pancreatic diseases. Represent a significant burden on healthcare systems worldwide. Objectives: To analyze the incidence of hospitalization, number of deaths and mortality rate of pancreatic diseases in patients treated in the Unified Health System (SUS), between 2016 and 2020, in different Brazilian regions. Methods: Analysis of hospitalization data for pancreatic diseases, using data from the Department of Informatics of the Unified Health System (DATASUS), calculating incidence using data from the Annual Population Estimate of the Brazilian Institute of Geography and Statistics, subtracted by the percentage of population with coverage for complementary health, through data from the Supplementary Health Agency. Results: In the period studied, the annual average of hospitalizations in Brazil by the SUS was 33,701 hospitalizations/year, representing 0.82% of hospitalizations. There was an average annual growth of 2.29% in the 05 years studied. In 2019, the incidence of hospitalizations for pancreatic diseases in the SUS was 21.25/100,000 persons, the highest in the Southeast region (28.55/100,000) and the lowest in the Northeast (11.59/100,000). Most hospitalizations occurred between 30 and 59 years old, mainly in males. The annual average of deaths in hospitalized patients was 1,711.4/year (5.09% of hospitalizations) and 1.06/100,000 persons, higher in men, with an increase from 55 years of age, mainly over 80 years, with little variation between different Brazilian regions. Conclusion: Pancreatic diseases are neglected diseases, with a large number of hospitalizations and hospital mortality that can be modified if there is early recognition.
Downloads
References
Amy Y Xiao, Marianne L Y Tan, Landy M Wu, Varsha M Asrani, John A Windsor, Dhiraj Yadav, et.al. Global incidence and mor¬tality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 2016; 1: 45–55
Dhiraj Yadav Albert B. Lowenfels. The Epidemiology of Pancre¬atitis and Pancreatic Cancer. Gastroenterology 2013; 144:1252– 1261
Jordan P. Iannuzzi, James A. King, Jessica Hope Leong, Michael Buie, Fox E. Underwood, Gilaad G. Kaplan. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis. Gastroenterology 2022; 162:122–134.
Isabelle Ribeiro Barbosa, Camila Alves dos Santos, Dyego Lean¬dro Bezerra de Souza. Pancreatic cancer in Brazil: mortality trends and projections until 2029. Arq Gastroenterol 2018. v. 55 nº 3 jul/set.
Acesso à saúde: 150 milhões de brasileiros dependem do SUS. Fonte: IBGE. Publicado em 23 de setembro de 2020 na Sum¬mit Saúde 2021(internet). Disponível em: https://summitsaude. estadao.com.br/desafios-no-brasil/acesso-a-saude-150-milhoes-de-brasileiros-dependem-do-sus/
Datasus.saude.gov.br(internet). Departamento de Informática do SUS – DATASUS. Disponível em: https://datasus.saude.gov. br/sobre-o-datasus.
Tenner, Scott, et al. “American College of Gastroenterology Guideline: Management of Acute Pancreatitis.” American Jour¬nal of Gastroenterology, vol. 108, no. 9, Sept. 2013, pp. 1400– 1415, 10.1038/ajg.2013.218.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
